Tanfac Inds.
Tanfac Industries Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
Guidance rank: #8 of 68 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
What the Q1 FY27 call signalled
5 of 5 strong
The short version
FY27 revenue growth targeted at around 30% compared to FY26 (Page 9, Page 6). TANFAC targets 30% revenue growth in FY27 driven by new project launch (HFC-32) and ramp-up of existing capacities.
From Tanfac Inds.'s Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- FY27 revenue growth targeted at around 30% compared to FY26 (Page 9, Page 6).
- FY28 revenue expected to grow over 60% due to ramp-up of new projects and inorganic fluoride products (Page 6).
- R-32 volume guidance for FY28 is conservatively at 80%-85% utilization (Page 9).
- Solar grade DHF capacity planned to expand alongside solar wafer capacity growth from 35 GW to 210 GW by FY29 (Page 20).
- AHF capacity expansion of 20,000 to 30,000 tons planned with commissioning expected by FY28 (Page 15).
2 more points from Tanfac Inds.'s call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Tanfac Inds. said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Current ongoing capex: HFC-32 project with a total committed liability of INR 315 crores out of INR 395 crores; about INR 100 crores spent so far; commissioning expected by November-end 2026.
- Future capex plans (~INR 1,500 - 1,700 crores over next 4 years) include:
- Expansion of Solar Grade DHF capacity (INR 30-40 crores), starting 6 months post HFC-32 commissioning.
- Expansion of AHF (Anhydrous Hydrogen Fluoride) capacity (INR 120 crores), expected 12-15 months timeline.
- Investment in value-added fluorochemicals and electronic-grade products, including inorganic fluorides and fluoropolymers (INR 150 crores).
2 more points from Tanfac Inds.'s call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Tanfac Inds. said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- TANFAC Industries Limited has two firm contracts for R-32 and one Memorandum of Understanding (MoU) which is expected to convert into a contract soon.
- The MoU offtake is for 5,000 tons.
- Around 80% to 85% of the solar grade DHF plant capacity is contracted.
- Approximately 65% to 70% of the R-32 capacity is already booked under long-term contracts spanning 5 to 8 years.
- Long-term contracts include take-or-pay terms with pass-through pricing mechanisms.
- The company has placed about 65% of R-32 volume at a fixed EBITDA margin with remaining 30% sold on the spot market.
2 more points from Tanfac Inds.'s call on order book
Create a free account to keep reading this call
Tanfac Inds. — Quarterly revenue & net profit
Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹193 Cr, net profit ₹18 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Tanfac Inds.'s management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Alufluoride (Q1 FY27)
Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr
- POCL Enterprises (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
- Devson Catalyst (Q1 FY27)
FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee
- Ambani Orgochem (Q1 FY27)
Financial highlights show Total Income in ₹ Lakhs: . Key investor presentation takeaways from Ambani Orgochem's Q1 FY27 investor presentation — and how it ranks
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Tanfac Inds. and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Tanfac Inds. Q1 FY27 results?
FY27 revenue growth targeted at around 30% compared to FY26 (Page 9, Page 6). TANFAC targets 30% revenue growth in FY27 driven by new project launch (HFC-32) and ramp-up of existing capacities.
What is Tanfac Inds. share price analysis?
Tanfac Inds. currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 104.0 with a market cap of ₹7,038 Cr. Investors should review the full earnings analysis for detailed insights.
Is Tanfac Inds. planning capital expenditure?
Current ongoing capex: HFC-32 project with a total committed liability of INR 315 crores out of INR 395 crores; about INR 100 crores spent so far; commissioning expected by November-end 2026.
Keep Tanfac Inds. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.